Newswise Focus Channel: Cancer Channel Featured Story TOP /articles/channels/Cancer Channel Featured Story TOP Newswise - Featured Cancer Channel: This channel focus on displaying breaking news, highlights experts reviews, research and feature stories related to Cancer. en-us Copyright 2024 Newswise Newswise Focus Channel: Cancer Channel Featured Story TOP 115 31 / /images/newswise-logo-rss.gif Exercise increases the number of cancer-destroying immune cells in cancer patients /articles/exercise-boosts-cancer-fighting-immune-cells/?sc=c6300 /articles/exercise-boosts-cancer-fighting-immune-cells/?sc=c6300 Tue, 02 May 2023 12:45:51 EST Two new Finnish studies show that short bouts of light or moderate exercise can increase the number of immune cells in the bloodstream of cancer patients. University of Turku (Turun yliopisto) New Study Shows More Deaths with Cancer as Contributing Cause During First Year of Pandemic /articles/new-study-shows-more-deaths-with-cancer-as-contributing-cause-during-first-year-of-pandemic/?sc=c6300 /articles/new-study-shows-more-deaths-with-cancer-as-contributing-cause-during-first-year-of-pandemic/?sc=c6300 Tue, 11 Apr 2023 16:00:00 EST <img src="/legacy/image.php?image=/images/uploads/2023/04/10/643418134e516_ZHAOCovidgraphic2.jpg&width=100&height=150" alt="Newswise image" />In a new study, American Cancer Society researchers discovered deaths with cancer as the underlying or primary cause decreased in the United States during the first year of the pandemic in 2020 compared to 2019, continuing the decreasing trend from prior years. In contrast, mortality rates with cancer as a contributing cause were higher in 2020 compared to 2019, reversing the decreasing trend from prior years. The study was published today in the Journal Oncology Practice. American Cancer Society (ACS) Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed /articles/penn-medicine-research-suggests-more-cancers-can-be-treated-with-drugs-than-previously-believed/?sc=c6300 /articles/penn-medicine-research-suggests-more-cancers-can-be-treated-with-drugs-than-previously-believed/?sc=c6300 Tue, 14 Mar 2023 06:05:31 EST Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Nature Communications, suggest there may be new opportunities to treat cancer with new or existing drugs. Perelman School of Medicine at the University of Pennsylvania MSU, international team find existing drug could reduce side effects of popular cancer treatment /articles/msu-international-team-find-existing-drug-could-reduce-side-effects-of-popular-cancer-treatment/?sc=c6300 /articles/msu-international-team-find-existing-drug-could-reduce-side-effects-of-popular-cancer-treatment/?sc=c6300 Wed, 30 Nov 2022 10:05:53 EST A Michigan State University researcher is part of an international team that found an existing drug may help decrease side effects of cisplatin, a widely used cancer treatment that was discovered at MSU in 1965. Michigan State University New Study Shows Segregation in U.S. Counties Influence Cancer Risk and Mortality /articles/new-study-shows-segregation-in-u-s-counties-influence-cancer-risk-and-mortality/?sc=c6300 /articles/new-study-shows-segregation-in-u-s-counties-influence-cancer-risk-and-mortality/?sc=c6300 Thu, 17 Nov 2022 11:00:00 EST <img src="/legacy/image.php?image=/images/uploads/2022/11/15/6373c4153228e_XuesongHanPhD.jpg&width=100&height=150" alt="Newswise image" />A new study led by researchers at the American Cancer Society and Clemson University shows residential racial and economic segregation was associated with cancer mortality at the county level in the United States. American Cancer Society (ACS) Appendiceal Cancer Gets Its Own Preclinical Model /articles/appendiceal-cancer-gets-its-own-preclinical-model/?sc=c6300 /articles/appendiceal-cancer-gets-its-own-preclinical-model/?sc=c6300 Tue, 01 Nov 2022 11:30:02 EST <img src="/legacy/image.php?image=/images/uploads/2022/11/01/636135b70f85b_Lowy-Andrew-400x530.jpg&width=100&height=150" alt="Newswise image" />Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed. University of California San Diego Study Shows Older Age and Smoking Most Important Risk Factors for Developing Any Cancer /articles/study-shows-older-age-and-smoking-most-important-risk-factors-for-developing-any-cancer/?sc=c6300 /articles/study-shows-older-age-and-smoking-most-important-risk-factors-for-developing-any-cancer/?sc=c6300 Wed, 03 Aug 2022 03:05:00 EST <img src="/legacy/image.php?image=/images/uploads/2022/08/02/62e9ad3f8ee28_CancerScreening4.jpg&width=100&height=150" alt="Newswise image" />A new large study led by researchers at the American Cancer Society shows older age and smoking are the two most important risk factors associated with a relative and absolute five-year risk of developing any cancer. The findings also demonstrate that in addition to age and smoking history, clinicians should consider excess body fatness, family history of any cancer, and several other factors that may help patients determine if they may benefit from enhanced cancer screening or prevention interventions. The data was published today in the journal Cancer. American Cancer Society (ACS) MD Anderson Research Highlights for May 4, 2022 /articles/md-anderson-research-highlights-for-may-4-2022/?sc=c6300 /articles/md-anderson-research-highlights-for-may-4-2022/?sc=c6300 Wed, 04 May 2022 12:05:46 EST Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection. University of Texas MD Anderson Cancer Center Sylvester Expert Co-Authors Guidelines for Optimizing Cancer Survivor Nutrition and Physical Activity /articles/sylvester-expert-co-authors-guidelines-for-optimizing-cancer-survivor-nutrition-and-physical-activity/?sc=c6300 /articles/sylvester-expert-co-authors-guidelines-for-optimizing-cancer-survivor-nutrition-and-physical-activity/?sc=c6300 Thu, 24 Mar 2022 14:15:24 EST <img src="/legacy/image.php?image=/images/uploads/2022/03/24/623cb03b90b30_CraneTracy.jpg&width=100&height=150" alt="Newswise image" />More scientific evidence about the importance of nutrition and physical activity for cancer survivors has emerged in the past 10 years, prompting the American Cancer Society (ACS) to update its guidance for physicians and patients. Sylvester Comprehensive Cancer Center Younger patients with appendicitis are more likely to have cancer of the appendix /articles/younger-patients-with-appendicitis-are-more-likely-to-have-cancer-of-the-appendix/?sc=c6300 /articles/younger-patients-with-appendicitis-are-more-likely-to-have-cancer-of-the-appendix/?sc=c6300 Thu, 17 Mar 2022 11:00:29 EST From 2004 to 2017, there was an increase in cancer of the appendix in acute appendicitis patients, especially among patients younger than 50 years old. American College of Surgeons (ACS) Study: Exposure to Phthalates -- the 'Everywhere Chemical' -- May Increase Children's Cancer Risk /articles/study-exposure-to-phthalates-the-everywhere-chemical-may-increase-children-s-cancer-risk/?sc=c6300 /articles/study-exposure-to-phthalates-the-everywhere-chemical-may-increase-children-s-cancer-risk/?sc=c6300 Wed, 16 Mar 2022 15:05:49 EST <img src="/legacy/image.php?image=/images/uploads/2022/03/16/62322c3bf22b5_3174611184_2bdddf4ffc_k.jpg&width=100&height=150" alt="Newswise image" />In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the "everywhere chemical," to higher incidence of specific childhood cancers. University of Vermont Pancreatic cancer cells feed off hyaluronic acid /articles/pancreatic-cancer-cells-feed-off-hyaluronic-acid/?sc=c6300 /articles/pancreatic-cancer-cells-feed-off-hyaluronic-acid/?sc=c6300 Thu, 27 Jan 2022 12:05:06 EST <img src="/legacy/image.php?image=/images/uploads/2022/01/27/61f2c88d6a2f9_Men-Scientists-Lab-Screen-Test.jpg&width=100&height=150" alt="Newswise image" />Hyaluronic acid, or HA, is a known presence in pancreatic tumors, but a new study from researchers at the University of Michigan Health Rogel Cancer Center shows that hyaluronic acid also acts as food to the cancer cells. These findings, recently published in eLife, provide insight into how pancreatic cancer cells grow and indicate new possibilities to treat them. Michigan Medicine - University of Michigan High-fiber diet associated with improved progression-free survival and response to immunotherapy in melanoma patients /articles/high-fiber-diet-associated-with-improved-progression-free-survival-and-response-to-immunotherapy-in-melanoma-patients/?sc=c6300 /articles/high-fiber-diet-associated-with-improved-progression-free-survival-and-response-to-immunotherapy-in-melanoma-patients/?sc=c6300 Thu, 23 Dec 2021 14:00:00 EST <img src="/legacy/image.php?image=/images/uploads/2021/12/16/203533_Wargo_J.jpg&width=100&height=150" alt="Newswise image" />Patients with melanoma who reported eating more fiber-rich foods when they began immunotherapy treatment survived longer without cancer growth than patients with insufficient dietary fiber intake, according to new research from The University of Texas MD Anderson Cancer Center published today in Science. University of Texas MD Anderson Cancer Center Belzutifan offers hope for patients with von Hippel-Lindau disease /articles/belzutifan-offers-hope-for-patients-with-von-hippel-lindau-disease/?sc=c6300 /articles/belzutifan-offers-hope-for-patients-with-von-hippel-lindau-disease/?sc=c6300 Thu, 16 Dec 2021 10:20:02 EST The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose. Michigan Medicine - University of Michigan Yale Cancer Center Trial Identifies New Treatment Option for Certain Patients with T-Cell Lymphoma /articles/yale-cancer-center-trial-identifies-new-treatment-option-for-certain-patients-with-t-cell-lymphoma/?sc=c6300 /articles/yale-cancer-center-trial-identifies-new-treatment-option-for-certain-patients-with-t-cell-lymphoma/?sc=c6300 Mon, 13 Dec 2021 15:55:38 EST <img src="/legacy/image.php?image=/images/uploads/2021/12/13/61b7ad8fa58ed_Francine Foss&width=100&height=150" alt="Newswise image" />The final results from a national phase 2 study including researchers from Yale Cancer Center show the drug tipifarnib increased survival rates for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The findings are being presented today at the 2021 American Society of Hematology (ASH) Annual Meeting & Exposition in Atlanta, Georgia. Yale Cancer Center/Smilow Cancer Hospital Drug combination found to keep chronic lymphocytic leukemia in young patients in remission for several years /articles/drug-combination-found-to-keep-chronic-lymphocytic-leukemia-in-young-patients-in-remission-for-several-years/?sc=c6300 /articles/drug-combination-found-to-keep-chronic-lymphocytic-leukemia-in-young-patients-in-remission-for-several-years/?sc=c6300 Mon, 13 Dec 2021 11:15:00 EST <img src="/legacy/image.php?image=/images/uploads/2021/12/08/61b1622b7b6e7_Matthew Davids_DFCI.jpg&width=100&height=150" alt="Newswise image" />Young patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to keep the cancer in remission. A new study by Dana-Farber Cancer Institute researchers suggests that a 2.5-year regimen involving ibrutinib and chemoimmunotherapy can provide deep, and lasting remissions of the disease. Dana-Farber Cancer Institute Researchers Discover How Cells From Tumors Remain Dormant for Years Before Metastasis Occurs /articles/researchers-discover-how-cells-from-tumors-remain-dormant-for-years-before-metastasis-occurs/?sc=c6300 /articles/researchers-discover-how-cells-from-tumors-remain-dormant-for-years-before-metastasis-occurs/?sc=c6300 Mon, 13 Dec 2021 11:00:00 EST Mount Sinai researchers have solved a major mystery in cancer research: How cancer cells remain dormant for years after they leave a tumor and travel to other parts of the body, before awakening to create metastatic cancer. Mount Sinai Health System FDA Approves "Glowing Tumor" Imaging Drug to Better Identify Ovarian Cancer Cells Using Approach Pioneered by Surgeons at the University of Pennsylvania /articles/fda-approves-glowing-tumor-imaging-drug-to-better-identify-ovarian-cancer-cells-using-approach-pioneered-by-surgeons-at-the-university-of-pennsylvania/?sc=c6300 /articles/fda-approves-glowing-tumor-imaging-drug-to-better-identify-ovarian-cancer-cells-using-approach-pioneered-by-surgeons-at-the-university-of-pennsylvania/?sc=c6300 Tue, 30 Nov 2021 13:40:26 EST <img src="/legacy/image.php?image=/images/uploads/2021/12/23/glowing tumor.png&width=100&height=150" alt="Newswise image" />FDA approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer. Perelman School of Medicine at the University of Pennsylvania The Medical Minute: Quitting smoking sooner could save your life /articles/the-medical-minute-quitting-smoking-sooner-could-save-your-life/?sc=c6300 /articles/the-medical-minute-quitting-smoking-sooner-could-save-your-life/?sc=c6300 Wed, 17 Nov 2021 15:30:44 EST <img src="/legacy/image.php?image=/images/uploads/2021/12/28/SMOKING1200.jpg&width=100&height=150" alt="Newswise image" />It's well known that smoking causes lung cancer. But a new study suggests you can lower―or even erase―the risk of dying from lung cancer associated with continuous smoking if you quit when you're young. Penn State Health Roswell Park Researchers Identify Key Link Between Stress and Cancer /articles/roswell-park-researchers-identify-key-link-between-stress-and-cancer/?sc=c6300 /articles/roswell-park-researchers-identify-key-link-between-stress-and-cancer/?sc=c6300 Fri, 05 Nov 2021 15:15:36 EST Stress can have a significant negative effect on health, but our understanding of how stress impacts the development and progression of cancer is just beginning. A team from Roswell Park Comprehensive Cancer Center has identified an important mechanism by which chronic stress weakens immunity and promotes tumor growth. Their findings, just published in Cell Reports, point to the beta-adrenergic receptor (β-AR) as a driver of immune suppression and cancer growth in response to stress, opening the possibility of targeting this receptor in cancer therapy and prevention. Roswell Park Comprehensive Cancer Center